Divergent Burden of Rheumatic and Non‐Rheumatic Heart Disease in the MENA Region (1990–2023): A Retrospective Global Burden of Disease Analysis and Projections to 2050
Health Science Reports · 2026-11 · 9 (11)
DOI: 10.1002/hsr2.73534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 18.11.2026. Verfasst von Faisal A. Al‐Harbi und 10 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Valvular heart disease in the Middle East and North Africa (MENA) region reflects two distinct processes. Rheumatic heart disease (RHD), which is tied to poverty and untreated streptococcal infection, and non‐rheumatic valvular heart disease (NRVHD), which is linked to population aging and metabolic risk. This study compared the burden of both conditions across the region from 1990 to 2023.
Methods
Age‐standardized mortality, incidence, and prevalence rates per 100,000 population were obtained from the Global Burden of Disease database for 21 MENA countries. Joinpoint regression estimated the average annual percentage change (AAPC), pairwise comparison tested whether the two conditions diverged, and mortality was projected through 2050.
Results
RHD mortality fell from 5.87 to 2.19 per 100,000 (AAPC −2.97%), despite a slight increase in incidence and a doubling of prevalent cases to 3.36 million. In contrast, NRVHD mortality rates remained stable while absolute deaths nearly tripled, accompanied by steady increases in incidence and prevalence, with prevalent cases more than tripling to 557,576. Women carried a higher RHD burden, whereas men accounted for the greater increase in NRVHD burden. The temporal trends for RHD and NRVHD were statistically distinct across all outcomes. By 2050, RHD mortality is projected to decline by approximately 51%, compared with a 2.9% decline in NRVHD mortality.
Conclusion
RHD and NRVHD exhibit contrasting trajectories across the MENA region, reflecting differences in their underlying epidemiology. These patterns call for distinct public health strategies, with greater emphasis on primary prevention of RHD and expansion of diagnostic and surgical capacity for NRVHD.
Zitieren
APA
Al‐Harbi, F. A., Alkuwaiti, M. A., Alsaif, A. K., Aljabr, M. N., Aldhowayan, L. T., Alsulmi, S. R., Alsulmi, S. S., Almushiqh, O. A., Alroshodi, A., Tesfaye, M., & Ashraf, H. (2026). Divergent Burden of Rheumatic and Non‐Rheumatic Heart Disease in the MENA Region (1990–2023): A Retrospective Global Burden of Disease Analysis and Projections to 2050. Health Science Reports, 9(11). https://doi.org/10.1002/hsr2.73534
Vancouver
Al‐Harbi FA, Alkuwaiti MA, Alsaif AK, Aljabr MN, Aldhowayan LT, Alsulmi SR, et al. Divergent Burden of Rheumatic and Non‐Rheumatic Heart Disease in the MENA Region (1990–2023): A Retrospective Global Burden of Disease Analysis and Projections to 2050. Health Science Reports. 2026;9(11). doi:10.1002/hsr2.73534
BibTeX
@article{AlHarbi2026,
author = {Al‐Harbi, Faisal A. and Alkuwaiti, Mohanad A. and Alsaif, Ahmed K. and Aljabr, Mohammed N. and Aldhowayan, Layan T. and Alsulmi, Sulaiman R. and Alsulmi, Shahad S. and Almushiqh, Obadh A. and Alroshodi, Abdulaziz and Tesfaye, Mahir and Ashraf, Hamza},
title = {Divergent Burden of Rheumatic and Non‐Rheumatic Heart Disease in the MENA Region (1990–2023): A Retrospective Global Burden of Disease Analysis and Projections to 2050},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {11},
doi = {10.1002/hsr2.73534}
}
EUVIMED